"Never Events" Rare Following Bladder Cancer Surgery

This article originally appeared here.
Share this content:
"Never Events" Rare After Bladder Cancer Surgery
"Never Events" Rare After Bladder Cancer Surgery

(HealthDay News) -- "Never events", ten hospital-acquired conditions deemed by the Centers for Medicare and Medicaid Services as being reasonably preventable, are rare in patients with bladder cancer who have undergone radical cystectomy, according to a study published in the March issue of Urology.

Gregory A. Joice, from Columbia University in New York City, and colleagues determined the rate of never events, where hospitals would no longer be reimbursed for the additional care if a patient developed any of these conditions, in 61,142 patients with bladder cancer who had undergone radical cystectomy from 2002 to 2009.

The researchers found that 2.42 percent of patients developed any never event condition, with vascular-catheter infections being the most common at 1.25 percent. The risk of a never event was higher for blacks and for those with comorbidities. A never event increased the average hospital stay by 15 days, increased total costs by $37,000, and increased in-hospital mortality to 8.0 percent from 2.2 percent.

"Centers for Medicare and Medicaid Services never events after radical cystectomy are rare events," Joice and colleagues conclude. "Vascular catheter infection and pressure ulcers were most common and were the only events with rates > 0.1 percent."

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs